F E B R U A R Y 2 01 8 • O U T PAT I E N TS U R G E R Y. N E T • 1 9
INNOVATIONS IN SURGERY
meet
the
mko
melt,
A
new
sublingual
sedative
The MKO Melt
®
is a sublingual compounded
formulation that consist of midazolam
3mg (sedative), ketamine HCl 25mg (anesthetic),
and ondansetron 2mg (antiemetic). It is available
from Imprimis' FDA Registered 503B Outsourcing
Facility and can be purchased without the need of
individual prescriptions. FDA Outsourcing Facilities
are required to follow cGMP guidelines to
safeguard the quality and safety of every
compounded medication dispensed.
Visit www.imprimisrx.com/order503b/
to order today!
*For professional use only. Imprimis Pharmaceuticals specializes
in customizing medications to meet unique patient and practitioner
needs. No compounded medication is reviewed by the FDA for
safety or efficacy. Imprimis Pharmaceuticals does not compound
copies of commercially available products. References available
upon request.
For
more
information
visit
www.imprimis.com.
This c-arm produces great
images, low radiation
Fluoroscan
®
Insight™ FD Mini C-Arm Imaging
System enriches mini C-Arm technology, offering:
• Diversified Imaging Options
• high-resolution mode that enables clinicians
to use full detector resolution
1
• low-dose mode to reduce the radiation up to
50 percent compared to Auto mode and still
get equivalent images
1
• MegaView™ Image in Review mode to display
a 50 percent larger image
1
.
• Upgraded Storage & Transport
• A streamlined monitor arm with integrated
keyboard, providing increased range of motion
• Simplified method for locking the C-arm that
also reduces the total width of the system
• Enhanced Interface
• New features include:
• an easy
1
zoom feature
• save notifications to identify saved images
1
• save filter to prioritize saved images
1
• auto-save option to automatically save images.
1
Data based on simulated use workflow survey with 6 clinicians. (2017)
For
more
information
visit
www.hologic.com.
